Amalgamated Bank Praxis Precision Medicines, Inc. Transaction History

Amalgamated Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$0.8 - $4.98 $128 - $796	-160 Reduced 3.41%	4,528 $4,000
Q3 2022 Nov 09, 2022	BUY	$2.5 - $37.95 $22 - $341	9 Added 0.19%	4,688 $11,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $11.34 $948 - $6,146	542 Added 13.1%	4,679 $11,000
Q1 2022 Jun 30, 2022	BUY	$10.21 - $20.29 $42,238 - $83,939	4,137 New	4,137 $42,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.